{"schema_version":"1","generated_at":"2026-10-30T06:01:34.310Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/kennedy-ukadike","json_url":"https://www.findmykol.com/kol/kennedy-ukadike/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"kennedy-ukadike","name":"Kennedy Ukadike","credential":"MD","specialty":"Rheumatology","specialty_raw":"Rheumatology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"institution":"Renown Health","institution_url":"https://www.findmykol.com/institution/renown-health","city":"Reno","state":"NV","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1346637295","orcid":"0000-0002-9028-6828","openalex":"A5069794289"},"summary":"Kennedy Ukadike is a Systemic Lupus Erythematosus Research physician affiliated with Renown Health. OpenAlex indexes 20 publications with 250 citations (h-index 9).","overview":{"text":"Kennedy C. Ukadike, M.D., is affiliated with Renown Health (Renown Rheumatology, Reno, NV). The public record shows 20 publications with 250 citations (h-index 9), centered on Systemic Lupus Erythematosus Research, Vasculitis and related conditions, Systemic Sclerosis and Related Diseases. It also documents industry payments reported by 8 companies.","bullets":["Most recent indexed publication: 2021 · Journal of clinical medicine","Top research focus: Systemic Lupus Erythematosus Research","Open Payments reporting from 8 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Lupus (SLE)","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":1,"strength":1}],"research_topics":["Systemic Lupus Erythematosus Research","Vasculitis and related conditions","Systemic Sclerosis and Related Diseases","Chromosomal and Genetic Variations","Genomics and Chromatin Dynamics"],"drugs_studied":{"total":11,"shown":3,"withheld":8,"rows":[{"name":"Benlysta","generic":"Belimumab","trials":0,"payments":9,"publications":0,"mentions":9},{"name":"Saphnelo","generic":"Anifrolumab","trials":0,"payments":2,"publications":0,"mentions":2},{"name":"Tremfya","generic":"Guselkumab","trials":0,"payments":2,"publications":0,"mentions":2}]},"works_with":{"total":8,"shown":3,"withheld":5,"rows":[{"name":"GlaxoSmithKline, LLC.","trials":0,"payments":10,"mentions":10},{"name":"AstraZeneca Pharmaceuticals LP","trials":0,"payments":2,"mentions":2},{"name":"Janssen Biotech, Inc.","trials":0,"payments":2,"mentions":2}]}},"scholarship":{"works_count":20,"cited_by_count":250,"h_index":9,"i10_index":9,"pubmed_count":1,"latest_activity_year":2024,"source":"works"},"trials":{"count":0,"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"company_count":8,"program_years":{"first":2022,"last":2024},"rows_total":11,"shown":3,"withheld":8,"rows":[{"payer":"GlaxoSmithKline, LLC.","program_year":2024,"amount_usd":210.25,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1346637295"},{"payer":"Janssen Biotech, Inc.","program_year":2024,"amount_usd":122.9,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1346637295"},{"payer":"Amgen Inc.","program_year":2024,"amount_usd":13.28,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1346637295"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1346637295","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":48.3,"classes_total":8,"classes":[{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":13.9,"drugs":[{"name":"Methotrexate","share_pct":100}],"max_beneficiaries":37},{"class":"Antirheumatic Agent","setting":"prescribed","share_pct":9.7,"drugs":[{"name":"Leflunomide","share_pct":100}],"max_beneficiaries":27}]},{"area":"Antiparasitic","share_pct":21.2,"classes_total":1,"classes":[{"class":"Antimalarial","setting":"prescribed","share_pct":21.2,"drugs":[{"name":"Hydroxychloroquine Sulfate","share_pct":100}],"max_beneficiaries":61}]},{"area":"Metabolism & gastrointestinal","share_pct":16,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":12.8,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":51},{"class":"Aminosalicylate","setting":"prescribed","share_pct":3.1,"drugs":[{"name":"Sulfasalazine Dr","share_pct":100}],"max_beneficiaries":12}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"publications":{"total":1,"shown":1,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Implications of Endogenous Retroelements in the Etiopathogenesis of Systemic Lupus Erythematosus.","year":2021,"journal":"Journal of clinical medicine","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/33669709/","status":"verified"}],"most_cited":{"total":20,"shown":5,"withheld":15,"rows":[{"title":"How Retroviruses and Retrotransposons in Our Genome May Contribute to Autoimmunity in Rheumatological Conditions","year":2020,"cited_by_count":56,"type":"article","source_url":"https://doi.org/10.3389/fimmu.2020.593891"},{"title":"High Prevalence and Disease Correlation of Autoantibodies Against p40 Encoded by Long Interspersed Nuclear Elements in Systemic Lupus Erythematosus","year":2019,"cited_by_count":41,"type":"article","source_url":"https://doi.org/10.1002/art.41054"},{"title":"POMGnT1 gene alterations in a family with neurological abnormalities","year":2004,"cited_by_count":36,"type":"article","source_url":"https://doi.org/10.1002/ana.20172"},{"title":"Autoantibodies against the envelope proteins of endogenous retroviruses K102 and K108 in patients with systemic lupus erythematosus correlate with active disease","year":2021,"cited_by_count":27,"type":"article","source_url":"https://doi.org/10.55563/clinexprheumatol/2kg1d8"},{"title":"Expression of L1 retrotransposons in granulocytes from patients with active systemic lupus erythematosus","year":2023,"cited_by_count":18,"type":"article","source_url":"https://doi.org/10.1186/s13100-023-00293-7"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Tomas Mustelin","coauthored_works":12},{"name":"Christian Lood","coauthored_works":7},{"name":"John LaCava","coauthored_works":6}],"source":"works"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD","source_url":"https://www.renown.org/find-a-doctor/1346637295-kennedy-ukadike-md","status":"provisional","collected_at":"2026-10-28"},{"value":"MS","source_url":"https://www.renown.org/find-a-doctor/1346637295-kennedy-ukadike-md","status":"provisional","collected_at":"2026-10-28"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Fellow, American College of Rheumatology (FACR)","source_url":"https://www.renown.org/find-a-doctor/1346637295-kennedy-ukadike-md","status":"provisional","collected_at":"2026-10-28"}]}},"similar":[{"name":"Nitesh Kuhadiya","slug":"nitesh-kuhadiya","institution":"Renown Health","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/nitesh-kuhadiya","json_url":"https://www.findmykol.com/kol/nitesh-kuhadiya/profile.json"},{"name":"Alexander Ayzengart","slug":"alexander-ayzengart","institution":"Renown Health","specialty":"Surgery","url":"https://www.findmykol.com/kol/alexander-ayzengart","json_url":"https://www.findmykol.com/kol/alexander-ayzengart/profile.json"},{"name":"Chia-Yang Hsu","slug":"chia-yang-hsu","institution":"Renown Health","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/chia-yang-hsu","json_url":"https://www.findmykol.com/kol/chia-yang-hsu/profile.json"},{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":8,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2022 to 2024","collected_at":"2026-10-28"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}